- Home
- DSM vs ANGO Comparison
DSM vs ANGO Comparison
Compare DSM & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$13.12
Company Overview
Basic Information| Metric | DSM | ANGO |
|---|---|---|
| Founded | 1989 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 301.5M | 400.8M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | DSM | ANGO |
|---|---|---|
| Price | $6.00 | $13.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 161.7K | ★ 430.9K |
| Earning Date | 01-01-0001 | 01-07-2026 |
| Dividend Yield | ★ 3.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | N/A | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $4.69 | $8.27 |
| 52 Week High | $6.05 | $13.99 |
Technical Indicators
Market Signals| Indicator | DSM | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 58.82 |
| Support Level | $5.99 | $13.12 |
| Resistance Level | $6.09 | $13.53 |
| Average True Range (ATR) | 0.06 | 0.43 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 61.11 | 61.80 |
Price Performance
Historical Comparison DSM
ANGO
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.